117,883 research outputs found
Iperenzimemia pancreatica benigna o sindrome di Gullo
No full textL'iperenzimemia pancreatica benigna è una sindrome che è stata descritta di recente da uno di noi (L.G.), caratterizzata da un abnorme aumento delle concentrazioni sieriche degli enzimi pancreatici in assenza di malattia pancreatica. L'iperenzimemia può riscontrarsi sporadicamente o in forma familiare, sia negli adulti, sia nei bambini. Una caratteristica importante è che l'elevazione degli enzimi nel siero è fluttuante, con frequenti e temporanei ritorni a livelli normali. In questo articolo descriveremo le principali caratteristiche della sindrome
Prevalência de câncer de próstata em pacientes portadores de cateter vesical de demora e diagnóstico presumido de hipeplasia benigna.
No full textTrabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Cirúrgica, Curso de Medicina, Florianópolis, 200
Tratamiento médico de la hiperplasia prostática benigna
No full textEl tratamiento de la hiperplasia prostática benigna se encuentra en una etapa de transición, por el desarrollo de variadas alternativas terapéuticas de tipo farmacológico o procedimientos de mínima invasión: dilataciones endoprostáticas con balones, tutores e incisiones o con el empleo del láser, microondas o del ultrasonido
Scheda computerizzata per uno studio prospettico sul trattamento dell'iperplasia prostatica benigna con ipertermia
No full textScheda computerizzata per uno studio prospettico sul trattamento dell'iperplasia prostatica benigna con ipertermi
Going Beyond Counting First Authors in Author Co-citation Analysis
No full textThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
No full textIn AL amyloidosis complete response (aCR) is defined as negative serum and urine immunofixation with normalized free light chain ratio (FLCR). However, achievement of low levels of involved FLC (iFLC) or difference between iFLC and uninvolved FLC (dFLC) are also relevant endpoints for treatment. We divided 434 consecutive patients with AL amyloidosis into five groups according to response 6 months after treatment initiation: aCR, iFLC <20 mg/L, normalized-iFLC, dFLC <10 mg/L, and normalized FLC ratio. Overall survival (OS) was similar (median not reached) in patients in aCR and in those who reached iFLC <20 mg/L, while it was inferior in all other groups (medians ranging from 79 to 91 months). Time to next therapy or death (TNTD) was longer in subjects attaining aCR (median 69 months) than in subjects reaching any FLC endpoint (medians ranging from 18 to 39 months). The ability of discriminating patients who survived more than 2 years among all responders was greater for current definition of aCR compared to combination of negative serum and urine immunofixation with any low-FLC endpoint. Complete response predicts best outcomes in AL amyloidosis and should be the goal of therapy if tolerability allows
Cirugía robótica en patología quirúrgica benigna y maligna (urología, cirugía general y digestiva, cirugía cardiotorácica, ginecología, endocrinología, oftalmología y cirugía de cabeza y cuello). Capítulo I: cirugía cardiotorácica, endocrina, oftalmológica y cirugía de cabeza y cuello
No full textCirurgia robòtica; Tècniques quirúrgiques; InnovacióCirugía robótica; Técnicas quirúrgicas; InnovaciónRobotic surgery; Surgical techniques; InnovationAquest estudi té l’objectiu de determinar si la cirurgia assistida per robot, quan aquesta és el tractament indicat en una sèrie de patologies benignes o malignes, ha de ser incorporada en la cartera comuna bàsica de serveis assistencials del SNS i, per tant, convertir-se en una tecnologia finançada a través de fons públics. Per fer-ho s’ha avaluat
l’eficàcia o l’efectivitat, la seguretat i l’eficiència de la cirurgia assistida per robot en comparació amb la cirurgia oberta o endoscòpica en un grup d’indicacions de patologia benigna o maligna en les especialitats de cirurgia cardiotoràcica, endocrina, oftalmològica, de cap i coll.El estudio tiene el objetivo de determinar si la cirugía asistida por robot, cuando la cirugía
es el tratamiento indicado en una serie de patologías benignas o malignas, debe ser incorporada en la cartera común básica de servicios asistenciales del SNS y, por tanto, convertirse en una tecnología financiada a través de fondos públicos. Para ello se ha evaluado la eficacia o la efectividad, la seguridad y la eficiencia de la cirugía asistida por robot en comparación con la cirugía abierta o endoscópica en un grupo de indicaciones de patología benigna o maligna en las especialidades de cirugía cardiotorácica, endocrina, oftalmológica y de cabeza y cuello.The aim of the report is to determine whether robot-assisted surgery —when surgery is the indicated treatment for a series of benign or malignant pathologies— should be included in the basic common portfolio of the SNS healthcare services and thus become a
publicly funded technology. To this end, the efficacy or effectiveness, safety and efficiency of robot-assisted surgery has been evaluated in comparison with open or endoscopic surgery in a group of indications of benign or malignant pathology in the specialities of cardiothoracic surgery, endocrine surgery, ophthalmological surgery, head and neck surgery
Square Dancing with the Stars to Enhance Dynamic Hirschman Linkages?
No full textIn this Presidential Address, the author takes the reader on a reconnaissance of his life and time as a regional scientist. He points out scenery he found scintillating along the way, hoping that some may pick up the banner and chew on a few of the ideas for a while. He suggests a revisit to Albert O. Hirschman’s notion of key sectors and more empirical analysis related to Marcus Berliant’s and Masahisa Fujita’s notion of knowledge creation and transfer.Presidential Address, San Antonio, Texas, March 29, 2014 (53rd Meetings of the Southern Regional Science Association
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
- …
